290 related articles for article (PubMed ID: 7350950)
1. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.
Wagner GC; Ricaurte GA; Seiden LS; Schuster CR; Miller RJ; Westley J
Brain Res; 1980 Jan; 181(1):151-60. PubMed ID: 7350950
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine.
Yamada S; Kojima H; Yokoo H; Tsutsumi T; Takamuki K; Anraku S; Nishi S; Inanaga K
Biol Psychiatry; 1988 Aug; 24(4):399-408. PubMed ID: 3408757
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum.
Nakayama M; Koyama T; Yamashita I
Brain Res; 1993 Jan; 601(1-2):209-12. PubMed ID: 8431767
[TBL] [Abstract][Full Text] [Related]
4. MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum.
Muraki A; Koyama T; Nakayama M; Ohmori T; Yamashita I
Neurosci Lett; 1992 Feb; 136(1):39-42. PubMed ID: 1353257
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Scalori V; Corsini GU
Ann N Y Acad Sci; 1998 May; 844():166-77. PubMed ID: 9668674
[TBL] [Abstract][Full Text] [Related]
6. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
Muraki A
Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
[TBL] [Abstract][Full Text] [Related]
7. MK-801 prevents methamphetamine-induced striatal dopamine damage and reduces extracellular dopamine overflow.
O'Dell SJ; Weihmuller FB; Marshall JF
Ann N Y Acad Sci; 1992 May; 648():317-9. PubMed ID: 1637061
[No Abstract] [Full Text] [Related]
8. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity.
O'Dell SJ; Weihmuller FB; Marshall JF
Brain Res; 1991 Nov; 564(2):256-60. PubMed ID: 1810626
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine-induced decrease in neural glucocorticoid receptors: relationship to monoamine levels.
Lowy MT; Novotney S
Brain Res; 1994 Feb; 638(1-2):175-81. PubMed ID: 8199858
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs.
Wagner GC; Seiden LS; Schuster CR
Drug Alcohol Depend; 1979 Sep; 4(5):435-8. PubMed ID: 510182
[TBL] [Abstract][Full Text] [Related]
11. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers.
Ricaurte GA; Seiden LS; Schuster CR
Brain Res; 1984 Jun; 303(2):359-64. PubMed ID: 6744029
[TBL] [Abstract][Full Text] [Related]
12. Characterization of high affinity dopamine uptake into the dopamine neurons of the hypothalamus.
George SR; Van Loon GR
Brain Res; 1982 Feb; 234(2):339-55. PubMed ID: 7059835
[TBL] [Abstract][Full Text] [Related]
13. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
14. Changes in sensitivity of dopamine autoreceptors in rat striatum after subchronic treatment with methamphetamine.
Yamada S; Yokoo H; Nishi S
Eur J Pharmacol; 1991 Nov; 205(1):43-7. PubMed ID: 1811995
[TBL] [Abstract][Full Text] [Related]
15. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow.
Weihmuller FB; O'Dell SJ; Marshall JF
Synapse; 1992 Jun; 11(2):155-63. PubMed ID: 1626313
[TBL] [Abstract][Full Text] [Related]
16. [Changes of the dopamine uptake sites in the rat striatum induced by repeated methamphetamine administration: a neurochemical approach to a mechanism of relapse in amphetamine psychosis].
Nakayama M
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):507-19. PubMed ID: 8340048
[TBL] [Abstract][Full Text] [Related]
17. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.
Kogan FJ; Nichols WK; Gibb JW
Eur J Pharmacol; 1976 Apr; 36(2):363-71. PubMed ID: 6286
[TBL] [Abstract][Full Text] [Related]
18. Contrasting tissue factors predict heterogeneous striatal dopamine neurotoxicity after MPTP or methamphetamine treatment.
Marshall JF; Navarrete RJ
Brain Res; 1990 Nov; 534(1-2):348-51. PubMed ID: 2073599
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice.
Fornai F; Bassi L; Torracca MT; Scalori V; Corsini GU
Eur J Pharmacol; 1995 Sep; 283(1-3):99-102. PubMed ID: 7498327
[TBL] [Abstract][Full Text] [Related]
20. [Thyrotropin-releasing hormone (TRH): action mechanism of an enhanced dopamine release from rat striatal slices (author's transl)].
Narumi S; Nagai Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1979 Apr; 75(3):239-50. PubMed ID: 119692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
